C-Polar Coated Filters for Reducing Air Pollution
(C-PolarLTC Trial)
Trial Summary
What is the purpose of this trial?
This is a CONTROLLED PROSPECTIVE COHORT study of a long-term care facility. At the start of the study a dedicated section A of the facility ventilation system will have routine HVAC filters of the same dimensions installed, while section B of the same facility ventilation system will have C-POLAR (cationic polymeric coated) HVAC filters installed. There will be continuous Indoor Air Quality monitors (PM 2.5, CO2, VOC, Radon, Temp, and RH) installed at different vent locations throughout the long-term care facility for the duration of the study. Air samples with an Airport MD8 BAMS machine will be taken once a week at various vent locations at the long-term care facility.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems unlikely that you would need to stop, as the study focuses on air quality and HVAC filters.
What data supports the effectiveness of the C-Polar coated HVAC Filter treatment for reducing air pollution?
Research shows that high-efficiency air filters, like HEPA and MERV 16, can significantly reduce indoor air pollution by lowering particulate matter levels, which are tiny particles in the air that can harm health. These filters have been shown to improve indoor air quality and provide health benefits, especially for people with allergies or asthma.12345
How does the C-Polar coated HVAC Filter treatment differ from other air filtration treatments?
The C-Polar coated HVAC Filter is unique because it uses a special coating to enhance air filtration efficiency, potentially overcoming limitations of traditional filters like difficulty in collecting conductive particles and operating in high humidity. This treatment may offer improved performance in reducing air pollution compared to standard filters, which often struggle with maintaining efficiency over time and under varying environmental conditions.46789
Research Team
Deanne Taylor, PhD
Principal Investigator
Kelowna General Hospital
Michael Mansour, MD, PhD
Principal Investigator
Harvard Medical School (HMS and HSDM)
Eligibility Criteria
This trial is for a long-term care facility looking to reduce bioaerosols, which are tiny particles in the air that can come from living organisms. The study does not specify individual participant criteria as it focuses on environmental interventions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Installation of C-POLAR HVAC filters in section B and routine HVAC filters in section A of the facility. Continuous monitoring of indoor air quality and weekly air sampling.
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- C-Polar coated HVAC Filter
Find a Clinic Near You
Who Is Running the Clinical Trial?
C-Polar Innovations
Lead Sponsor
Kelowna General Hospital
Collaborator